Read More 2 minute read Pharma Industry News AbbVie acquires Celsius Therapeutics to enhance inflammatory disease treatment options In a significant move within the biotechnology industry, AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, has completed… byPallavi MadhirajuJune 27, 2024